comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 11:08:46 - browse：58

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Lasker Awards 2023: Winners in biomedical research

WSS

HCA says smaller share of spending going to labor

Many immigrants are left out of maternal health programs

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Readout LOUD podcast: possible new ALS drug, artificial wombs

Judge orders hearing on Trump's motion to disqualify Fulton County DA

Second xenotransplant done with gene

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Psychedelics group wrestles with new pharma identity

5 wounded, 2 critically, in Michigan shopping center shooting

Anesthesiologist group: stop taking Ozempic before surgery

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Affirmative action in medical school literally saved lives

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

State Dept. review finds Biden bears some blame for Afghanistan failures

Teacher posts viral 'school supply rant' with advice for parents

ChatGPT in medicine: STAT answers readers' burning questions

Microbiome research is starting to find links to chronic diseases

focus

Many immigrants are left out of maternal health programs

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

CDC's new outbreak response network to include Northeastern

Doctors in states that ban abortion can still help patients

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Thermo Fisher plant for manufacturing gene therapies to expand

focus

focus

hotspot

focus